Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Esperer Nutrition, legally incorporated as Esperer Onco Nutrition Private Limited, is an India-based clinical nutrition and nutraceutical company focused on condition-specific nutritional therapies, with particular emphasis on oncology supportive care. The company markets research-based nutrition products intended to help manage cancer-related malnutrition, cachexia-anorexia syndrome, treatment-phase inflammation, recovery, and gastrointestinal cancer nutrition needs. Its portfolio includes products such as Es-Invigour, Es-Fortitude Nourish, Es-Fortitude Protect, Es Fortitude Recover, and Es-Fortitude GH, and it also promotes a broader disease-specific nutrition portfolio beyond oncology. Esperer positions itself around science-backed complementary nutrition therapy rather than drug development, supported by its Esperer Nutrition Development Centre and published clinical/post-marketing materials. The business appears to be a private, active, commercial-stage healthcare company rather than a traditional therapeutics biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Esperer Nutrition.